Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 19;28(18):3185-91.
doi: 10.1016/j.vaccine.2010.02.046. Epub 2010 Feb 26.

Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon

Affiliations

Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-gamma and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon

J C Lima-Junior et al. Vaccine. .

Abstract

Plasmodium vivax merozoite surface protein (PvMSP9) stimulates both cellular and humoral immune responses in individuals who are naturally infected by this parasite species. To identify immunodominant human T-cell epitopes in PvMSP9, we used the MHC class II binding peptide prediction algorithm ProPred. Eleven synthetic peptides representing predicted putative promiscuous T-cell epitopes were tested in IFN-gamma and IL-4 ELISPOT assays using peripheral blood mononuclear cells (PBMC) derived from 142 individuals from Rondonia State, Brazil who had been naturally exposed to P. vivax infections. To determine whether the predicted epitopes are preferentially recognized in the context of multiple alleles, MHC Class II typing of the cohort was also performed. Five synthetic peptides elicited robust cellular responses, and the overall frequencies of IFN-gamma and IL-4 responders to at least one of the promiscuous peptides were 62% and 46%, respectively. The frequencies of IFN-gamma and IL-4 responders to each peptide were not associated with a particular HLA-DRB1 allelic group since most of the peptides induced a response in individuals of 12 out of 13 studied allelic groups. The prediction of promiscuous epitopes using ProPred led to the identification of immunodominant epitopes recognized by PBMC from a significant proportion of a genetically heterogeneous population exposed to malaria infections. The combination of several such T-cell epitopes in a vaccine construct may increase the frequency of responders and the overall efficacy of subunit vaccines in genetically distinct populations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of positive responders (a) and number of spots (b) in ELISpot IFN-γ and IL-4 responses to PvMSP9 synthetic peptides (pE, pH, pJ, pK and pL) in individuals naturally exposed to malaria infections. (*) Significant differences (p< 0.01) for the comparison between the frequencies of IFN-γ responders with IL-4 responders, for each peptide calculated using χ2 test.
Figure 2
Figure 2
Venn diagram showing the relationships among the cellular responses to overlapping peptides pH, pK and pL sequences. Intersection points between the responders represent the number of positive individuals for two or three overlapping peptides.
Figure 3
Figure 3
Frequency of HLA-DRB1* (a) and HLA-DQB1 (b) alleles distribution in the 142 individuals studied. * indicates that the proportion of HLA-DRB1*04 predominate over all others HLA-DRB1* studied alleles (χ2 =6.043; p<0.0140) and # indicates that the proportion of DQB1*03 predominate over all other studied DQB1* alleles (χ2 =52.450; p<0.0001).

Similar articles

Cited by

References

    1. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009 Sep;9(9):555–66. - PubMed
    1. Baird JK. Age-dependent characteristics of protection v. susceptibility to Plasmodium falciparum. Ann Trop Med Parasitol. 1998 Jun;92(4):367–90. - PubMed
    1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79–87. - PMC - PubMed
    1. Galinski MR, Barnwell JW. Plasmodium vivax: who cares? Malar J. 2008;7( Suppl 1):S9. - PMC - PubMed
    1. Stephens R, Langhorne J. Priming of CD4+ T cells and development of CD4+ T cell memory; lessons for malaria. Parasite Immunol. 2006 Jan–Feb;28(1–2):25–30. - PubMed

Publication types